🇺🇸 FDA
Patent

US 10233206

D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response

granted A61KA61K31/445A61K31/7008

Quick answer

US patent 10233206 (D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response) held by SERGIO PUMAROLA SEGURA expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SERGIO PUMAROLA SEGURA
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/445, A61K31/7008, A61K31/7048, A61K36/48